Division of Social Research in Medicines and Health, School of Pharmacy, University of Nottingham, East Drive, University Park, Nottingham NG7 2RD, UK.
Res Social Adm Pharm. 2014 Jan-Feb;10(1):58-71. doi: 10.1016/j.sapharm.2013.03.003. Epub 2013 Apr 19.
The New Medicine Service (NMS) was introduced to community pharmacies in England in October 2011. The NMS aims to improve adherence to new medicines in patients with selected long term conditions. The service consists of two follow-up consultations within 1 month in addition to usual care.
This study explored community pharmacist and superintendent pharmacist views and experiences of the NMS in the 5 weeks prior to its implementation to identify potential facilitators and barriers to its success. The study also investigated participant experiences of the introduction and provision of existing pharmacy services in order to contrast with the implementation of the NMS.
This study consisted of four focus groups with a total of 15 community pharmacists representing locums and employees of small, medium and large chain pharmacies. In addition, 5 semi-structured interviews were conducted with superintendent pharmacists representing independent, small chain, supermarket and large multiple pharmacies. Data were audio-recorded, transcribed verbatim and thematically analyzed.
Both pharmacists and superintendent pharmacists were positive about the NMS and identified potential benefits for patients and the pharmacy profession. Awareness of the service was high, however, some confusion between the NMS and changes to Medicine Use Reviews was evident in all focus groups due to their similarity and coincidental implementation. This confusion was not observed in the interviews with superintendent pharmacists. Participants identified pharmacists' positive attitude, the similarity to current practice and the self-accreditation procedure as potential facilitators to service implementation. Potential barriers identified included a perceived lack of interest and awareness by GPs of the service, and the payment structure. Participants were concerned about the speed of implementation, and the absence of some materials needed prior to the start of the service.
Participants were enthusiastic about the potential of the NMS to benefit patients and the pharmacy profession. Participants were able to identify several potential barriers and facilitators to the provision of the service. It remains to be seen whether the factors identified affected the early implementation of the service.
新医药服务（NMS）于 2011 年 10 月在英格兰的社区药房推出。NMS 的目的是提高选定长期疾病患者对新药的依从性。该服务包括在常规护理之外的 1 个月内进行两次随访咨询。
本研究在新医药服务实施前的 5 周内探讨了社区药剂师和主管药剂师对新医药服务的看法和经验，以确定其成功的潜在促进因素和障碍。该研究还调查了参与者对现有药房服务的引入和提供的经验，以便与新医药服务的实施形成对比。
本研究包括四个焦点小组，共有 15 名社区药剂师代表小型、中型和大型连锁药店的临时工和员工。此外，还对代表独立、小型连锁、超市和大型连锁药店的 5 名主管药剂师进行了 5 次半结构化访谈。数据进行了录音、逐字转录和主题分析。
药剂师和主管药剂师对 NMS 持积极态度，并确定了对患者和药房行业的潜在好处。尽管服务意识很高，但由于相似性和巧合的实施，所有焦点小组中都存在 NMS 与药物使用审查变化之间的混淆。在与主管药剂师的访谈中没有观察到这种混淆。参与者确定了药剂师的积极态度、与当前实践的相似性以及自我认证程序是服务实施的潜在促进因素。确定的潜在障碍包括 GP 对该服务的兴趣和意识缺乏，以及支付结构。参与者担心服务的实施速度，以及在服务开始前缺乏一些必要的材料。
参与者对 NMS 为患者和药房行业带来的潜在好处充满热情。参与者能够确定提供该服务的一些潜在障碍和促进因素。目前尚不清楚确定的因素是否影响了服务的早期实施。
